FDA limits J&J COVID-19 vaccine due to rare blood clot risk

 The announcement follows a recommendation from the Centers for Disease Control and Prevention late last year to opt for either Pfizer or Moderna, over the single-shot J&J vaccine after a review of new CDC data on rare blood clots linked to J&J.

https://abcnews.go.com/Health/fda-limits-jj-covid-19-vaccine-due-rare/story